This inventor holds 5 USPTO granted patents. Top assignees: Novo Nordisk A/s, Novozymes A/s. Active years: 1997-2002.
Company Filing History:
Years Active: 1997-2002
Title: Ruby Illum Nielsen: Innovator in Enzymatic Technologies
Introduction
Ruby Illum Nielsen is a distinguished inventor based in Farum, Denmark. She has made significant contributions to the field of enzymatic technologies, holding a total of 5 patents. Her work focuses on the development of innovative methods and preparations that enhance the production of saccharides and other valuable compounds.
Latest Patents
Among her latest patents is the invention of a microbial xyloglucan endotransglycosylase (XET). This invention was discovered through a screening assay that revealed XET activity produced by a diverse range of microorganisms. The patent relates to a preparation of xyloglucan endotransglycosylase that can be produced by cultivating a microorganism that expresses XET. Another notable patent is a method for producing saccharide preparations, which involves saccharifying a liquefied starch solution. This method includes enzymatic saccharification stages and high-temperature membrane separation steps, allowing for efficient production of syrups and other saccharide products.
Career Highlights
Ruby has worked with prominent companies in the biotechnology sector, including Novo Nordisk A/S and Novozymes A/S. Her experience in these organizations has allowed her to develop and refine her innovative approaches to enzymatic processes.
Collaborations
Throughout her career, Ruby has collaborated with notable professionals in her field, including Gin C Liaw and Sven Pedersen. These collaborations have contributed to her success and the advancement of her inventions.
Conclusion
Ruby Illum Nielsen is a remarkable inventor whose work in enzymatic technologies has led to significant advancements in the production of saccharides. Her innovative patents and collaborations highlight her impact on the field and her commitment to scientific progress.